Assignee
LEUVAS THERAPEUTICS
US·1 granted patent·5 pending applications·0 citations·filing 2014–2021
Top patents by PatentIndex Score
6 records- 0156US2021332139A1Modulation of leukocyte activity in treatment of neuroinflammatory degenerative diseaseLEUVAS THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0255US2015104467A1Modulation of leukocyte activity in treatment of neuroinflammatory degenerative diseaseLEUVAS THERAPEUTICS·Filed 2014·Application pending·0 cites
- 0347US2021011030A1BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASELEUVAS THERAPEUTICS·Filed 2020·Application pending·0 cites
- 0444US2017253657A1Modulation of leukocyte activity in treatment of neuroinflammatory degenerative diseaseLEUVAS THERAPEUTICS·Filed 2017·Application pending·0 cites
- 0544US2017328919A1BLOCKADE OF TIM-1 PATHWAYS and P-SELECTIN PATHWAYS IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASELEUVAS THERAPEUTICS·Filed 2017·Application pending·0 cites
- 0626US10898548B2Modulators of protein tyrosine phosphatase and uses thereofLEUVAS THERAPEUTICS·Filed 2016·Granted Jan 26, 2021·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when LEUVAS THERAPEUTICS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →